nodes	percent_of_prediction	percent_of_DWPC	metapath
Thalidomide—TNF—periodontitis	0.524	0.678	CbGaD
Thalidomide—PTGS2—periodontitis	0.249	0.322	CbGaD
Thalidomide—Lenalidomide—TNFSF11—periodontitis	0.00791	0.726	CrCbGaD
Thalidomide—NFKB1—mouth—periodontitis	0.00515	0.105	CbGeAlD
Thalidomide—PTGS2—periosteum—periodontitis	0.00413	0.0843	CbGeAlD
Thalidomide—FGFR2—mouth—periodontitis	0.00386	0.0789	CbGeAlD
Thalidomide—NFKB1—trigeminal ganglion—periodontitis	0.0038	0.0775	CbGeAlD
Thalidomide—NFKB1—parotid gland—periodontitis	0.00358	0.0731	CbGeAlD
Thalidomide—FGFR2—neck—periodontitis	0.0033	0.0675	CbGeAlD
Thalidomide—CRBN—trigeminal ganglion—periodontitis	0.00318	0.065	CbGeAlD
Thalidomide—NFKB1—connective tissue—periodontitis	0.00315	0.0644	CbGeAlD
Thalidomide—CRBN—parotid gland—periodontitis	0.003	0.0613	CbGeAlD
Thalidomide—FGFR2—connective tissue—periodontitis	0.00237	0.0483	CbGeAlD
Thalidomide—FGFR2—epithelium—periodontitis	0.00225	0.0459	CbGeAlD
Thalidomide—PTGS1—endothelium—periodontitis	0.00159	0.0325	CbGeAlD
Thalidomide—PTGS2—endothelium—periodontitis	0.00152	0.0311	CbGeAlD
Thalidomide—Pomalidomide—TNF—periodontitis	0.0015	0.138	CrCbGaD
Thalidomide—CYP1A1—mouth—periodontitis	0.0014	0.0286	CbGeAlD
Thalidomide—PTGS2—mouth—periodontitis	0.00117	0.024	CbGeAlD
Thalidomide—CYP1A1—parotid gland—periodontitis	0.000974	0.0199	CbGeAlD
Thalidomide—PTGS2—trigeminal ganglion—periodontitis	0.000867	0.0177	CbGeAlD
Thalidomide—CYP1A1—epithelium—periodontitis	0.000814	0.0166	CbGeAlD
Thalidomide—Lenalidomide—PTGS2—periodontitis	0.000768	0.0705	CrCbGaD
Thalidomide—PTGS1—connective tissue—periodontitis	0.000753	0.0154	CbGeAlD
Thalidomide—PTGS2—connective tissue—periodontitis	0.00072	0.0147	CbGeAlD
Thalidomide—PTGS1—epithelium—periodontitis	0.000715	0.0146	CbGeAlD
Thalidomide—Pomalidomide—PTGS2—periodontitis	0.000714	0.0656	CrCbGaD
Thalidomide—PTGS2—epithelium—periodontitis	0.000683	0.0139	CbGeAlD
Thalidomide—CYP2C9—Arachidonic acid metabolism—PTGS2—periodontitis	8.59e-05	0.000512	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—TLR2—periodontitis	8.55e-05	0.000509	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—FCGR3A—periodontitis	8.54e-05	0.000509	CbGpPWpGaD
Thalidomide—NFKB1—Toll-like Receptor Signaling Pathway—IL6—periodontitis	8.48e-05	0.000506	CbGpPWpGaD
Thalidomide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—periodontitis	8.31e-05	0.000495	CbGpPWpGaD
Thalidomide—CYP1A1—Aryl Hydrocarbon Receptor—TNF—periodontitis	8.31e-05	0.000495	CbGpPWpGaD
Thalidomide—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—IL6—periodontitis	8.29e-05	0.000494	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—periodontitis	8.21e-05	0.000489	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—CXCL8—periodontitis	8.19e-05	0.000488	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—periodontitis	8.19e-05	0.000488	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CD79A—periodontitis	8.13e-05	0.000485	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—CD14—periodontitis	8.12e-05	0.000484	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by Interleukins—IL6—periodontitis	8.1e-05	0.000483	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—FCGR3A—periodontitis	8.1e-05	0.000483	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—CCL2—periodontitis	8.01e-05	0.000477	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	7.96e-05	0.000474	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—IL1B—periodontitis	7.86e-05	0.000468	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—periodontitis	7.85e-05	0.000468	CbGpPWpGaD
Thalidomide—NFKB1—Activated TLR4 signalling—IL6—periodontitis	7.82e-05	0.000466	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CD79A—periodontitis	7.72e-05	0.00046	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—CD14—periodontitis	7.71e-05	0.000459	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—IL1B—periodontitis	7.68e-05	0.000458	CbGpPWpGaD
Thalidomide—FGFR2—Disease—ACP5—periodontitis	7.67e-05	0.000457	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—TGFB1—periodontitis	7.63e-05	0.000455	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by NGF—FGF2—periodontitis	7.57e-05	0.000451	CbGpPWpGaD
Thalidomide—NFKB1—MAPK Signaling Pathway—TGFB1—periodontitis	7.55e-05	0.00045	CbGpPWpGaD
Thalidomide—CYP2C19—Biological oxidations—GGT1—periodontitis	7.54e-05	0.000449	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—VCAM1—periodontitis	7.53e-05	0.000448	CbGpPWpGaD
Thalidomide—NFKB1—SIDS Susceptibility Pathways—TNF—periodontitis	7.48e-05	0.000446	CbGpPWpGaD
Thalidomide—TNF—MAPK Signaling Pathway—IL1B—periodontitis	7.4e-05	0.000441	CbGpPWpGaD
Thalidomide—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—IL6—periodontitis	7.35e-05	0.000438	CbGpPWpGaD
Thalidomide—CYP1A2—Arachidonic acid metabolism—PTGS2—periodontitis	7.34e-05	0.000438	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—periodontitis	7.3e-05	0.000435	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCL3—periodontitis	7.28e-05	0.000434	CbGpPWpGaD
Thalidomide—TNF—Selenium Micronutrient Network—IL6—periodontitis	7.27e-05	0.000433	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by Insulin receptor—IL6—periodontitis	7.26e-05	0.000433	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—IFNG—periodontitis	7.24e-05	0.000431	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	7.18e-05	0.000428	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by NGF—FGF2—periodontitis	7.18e-05	0.000428	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—VCAM1—periodontitis	7.14e-05	0.000426	CbGpPWpGaD
Thalidomide—TNF—Adipogenesis—TGFB1—periodontitis	7.06e-05	0.000421	CbGpPWpGaD
Thalidomide—NFKB1—Cellular responses to stress—CXCL8—periodontitis	7.06e-05	0.000421	CbGpPWpGaD
Thalidomide—NFKB1—MAPK Signaling Pathway—TNF—periodontitis	7.05e-05	0.00042	CbGpPWpGaD
Thalidomide—PTGS1—Selenium Micronutrient Network—TNF—periodontitis	7.02e-05	0.000418	CbGpPWpGaD
Thalidomide—TNF—TNF alpha Signaling Pathway—IL6—periodontitis	7.02e-05	0.000418	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CXCL3—periodontitis	6.91e-05	0.000412	CbGpPWpGaD
Thalidomide—CYP2C9—Biological oxidations—GGT1—periodontitis	6.87e-05	0.00041	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—SLC52A3—periodontitis	6.82e-05	0.000406	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	6.82e-05	0.000406	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—IFNG—periodontitis	6.81e-05	0.000406	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—PPARA—periodontitis	6.78e-05	0.000404	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—AGER—periodontitis	6.66e-05	0.000397	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—IL6—periodontitis	6.62e-05	0.000395	CbGpPWpGaD
Thalidomide—NFKB1—Toll-Like Receptors Cascades—IL6—periodontitis	6.55e-05	0.00039	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—FCGR2A—periodontitis	6.51e-05	0.000388	CbGpPWpGaD
Thalidomide—PTGS2—Disease—SLC52A3—periodontitis	6.47e-05	0.000385	CbGpPWpGaD
Thalidomide—TNF—Toll-like Receptor Signaling Pathway—IL6—periodontitis	6.46e-05	0.000385	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—IL1B—periodontitis	6.46e-05	0.000385	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	6.36e-05	0.000379	CbGpPWpGaD
Thalidomide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—periodontitis	6.36e-05	0.000379	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—CXCL8—periodontitis	6.33e-05	0.000377	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—AGER—periodontitis	6.32e-05	0.000376	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by SCF-KIT—IL6—periodontitis	6.21e-05	0.00037	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—FCGR2A—periodontitis	6.18e-05	0.000368	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—MET—periodontitis	6.17e-05	0.000368	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—IL1B—periodontitis	6.08e-05	0.000362	CbGpPWpGaD
Thalidomide—NFKB1—Myometrial Relaxation and Contraction Pathways—IL6—periodontitis	6.07e-05	0.000362	CbGpPWpGaD
Thalidomide—NFKB1—SIDS Susceptibility Pathways—IL6—periodontitis	6.04e-05	0.00036	CbGpPWpGaD
Thalidomide—FGFR2—Downstream signaling of activated FGFR—IL6—periodontitis	5.94e-05	0.000354	CbGpPWpGaD
Thalidomide—CYP1A2—Biological oxidations—GGT1—periodontitis	5.87e-05	0.00035	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by ERBB4—IL6—periodontitis	5.85e-05	0.000349	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—CRP—periodontitis	5.81e-05	0.000346	CbGpPWpGaD
Thalidomide—TNF—MAPK Signaling Pathway—TGFB1—periodontitis	5.75e-05	0.000343	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—IL6—periodontitis	5.75e-05	0.000343	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—MMP9—periodontitis	5.73e-05	0.000341	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—periodontitis	5.68e-05	0.000338	CbGpPWpGaD
Thalidomide—PTGS1—Selenium Micronutrient Network—IL6—periodontitis	5.67e-05	0.000338	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CCR2—periodontitis	5.64e-05	0.000336	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL1RN—periodontitis	5.62e-05	0.000335	CbGpPWpGaD
Thalidomide—FGFR2—Downstream signal transduction—IL6—periodontitis	5.59e-05	0.000333	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—TNF—periodontitis	5.57e-05	0.000332	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—TLR4—periodontitis	5.57e-05	0.000332	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by FGFR—IL6—periodontitis	5.56e-05	0.000331	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by ERBB2—IL6—periodontitis	5.53e-05	0.00033	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—CRP—periodontitis	5.51e-05	0.000328	CbGpPWpGaD
Thalidomide—FGFR2—DAP12 signaling—IL6—periodontitis	5.5e-05	0.000328	CbGpPWpGaD
Thalidomide—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—periodontitis	5.46e-05	0.000325	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—SLC52A3—periodontitis	5.41e-05	0.000323	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CCR2—periodontitis	5.36e-05	0.000319	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL1RN—periodontitis	5.33e-05	0.000318	CbGpPWpGaD
Thalidomide—TNF—Adipogenesis—IL6—periodontitis	5.32e-05	0.000317	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—periodontitis	5.3e-05	0.000316	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—periodontitis	5.3e-05	0.000316	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—TLR4—periodontitis	5.28e-05	0.000315	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—VIP—periodontitis	5.26e-05	0.000314	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—TLR2—periodontitis	5.25e-05	0.000313	CbGpPWpGaD
Thalidomide—NFKB1—Cellular Senescence—IL6—periodontitis	5.25e-05	0.000313	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	5.19e-05	0.000309	CbGpPWpGaD
Thalidomide—FGFR2—DAP12 interactions—IL6—periodontitis	5.18e-05	0.000309	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by FGFR in disease—IL6—periodontitis	5.18e-05	0.000309	CbGpPWpGaD
Thalidomide—FGFR2—Fc epsilon receptor (FCERI) signaling—IL6—periodontitis	5.18e-05	0.000309	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—PPARA—periodontitis	5.16e-05	0.000308	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—MMP2—periodontitis	5.14e-05	0.000307	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by EGFR—IL6—periodontitis	5.13e-05	0.000306	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—SLC52A3—periodontitis	5.1e-05	0.000304	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by EGFR in Cancer—IL6—periodontitis	5.09e-05	0.000303	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—SLC52A3—periodontitis	5.09e-05	0.000303	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by PDGF—IL6—periodontitis	5.06e-05	0.000302	CbGpPWpGaD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL6—periodontitis	5.05e-05	0.000301	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—GGT1—periodontitis	5.02e-05	0.000299	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—VIP—periodontitis	5e-05	0.000298	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—TLR2—periodontitis	4.98e-05	0.000297	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD79A—periodontitis	4.93e-05	0.000294	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	4.92e-05	0.000293	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—FGF2—periodontitis	4.89e-05	0.000291	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—SLC52A3—periodontitis	4.81e-05	0.000286	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD14—periodontitis	4.73e-05	0.000282	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—TGFB1—periodontitis	4.72e-05	0.000281	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—MET—periodontitis	4.7e-05	0.00028	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCR2—periodontitis	4.69e-05	0.00028	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD79A—periodontitis	4.68e-05	0.000279	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—IL6—periodontitis	4.6e-05	0.000274	CbGpPWpGaD
Thalidomide—FGFR2—NGF signalling via TRKA from the plasma membrane—IL6—periodontitis	4.59e-05	0.000273	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—VCAM1—periodontitis	4.56e-05	0.000272	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—IL6—periodontitis	4.5e-05	0.000268	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD14—periodontitis	4.49e-05	0.000267	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CXCR2—periodontitis	4.45e-05	0.000265	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—TNF—periodontitis	4.41e-05	0.000263	CbGpPWpGaD
Thalidomide—PTGS2—Disease—LTF—periodontitis	4.39e-05	0.000262	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—VCAM1—periodontitis	4.33e-05	0.000258	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—FGF2—periodontitis	4.32e-05	0.000257	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—FGF2—periodontitis	4.14e-05	0.000247	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—FGF2—periodontitis	4.09e-05	0.000244	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL1A—periodontitis	4.05e-05	0.000241	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL18—periodontitis	4.04e-05	0.000241	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—ACP5—periodontitis	4.02e-05	0.00024	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	3.99e-05	0.000238	CbGpPWpGaD
Thalidomide—NFKB1—Cellular responses to stress—IL6—periodontitis	3.96e-05	0.000236	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—SLC52A3—periodontitis	3.93e-05	0.000234	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—FGF2—periodontitis	3.93e-05	0.000234	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—MMP2—periodontitis	3.92e-05	0.000234	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—AGER—periodontitis	3.88e-05	0.000231	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—MMP9—periodontitis	3.87e-05	0.00023	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL1A—periodontitis	3.84e-05	0.000229	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL18—periodontitis	3.83e-05	0.000228	CbGpPWpGaD
Thalidomide—PTGS2—Disease—ACP5—periodontitis	3.81e-05	0.000227	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—IL6—periodontitis	3.78e-05	0.000225	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—FGF2—periodontitis	3.72e-05	0.000222	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by NGF—IL6—periodontitis	3.72e-05	0.000222	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—AGER—periodontitis	3.68e-05	0.000219	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CCR2—periodontitis	3.65e-05	0.000217	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—ADRB1—periodontitis	3.63e-05	0.000216	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	3.59e-05	0.000214	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—SLC52A3—periodontitis	3.59e-05	0.000214	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—IL6—periodontitis	3.56e-05	0.000212	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—periodontitis	3.54e-05	0.000211	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by NGF—IL6—periodontitis	3.53e-05	0.00021	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CCR2—periodontitis	3.46e-05	0.000206	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—ADRB1—periodontitis	3.45e-05	0.000205	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CRP—periodontitis	3.38e-05	0.000201	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—TLR4—periodontitis	3.24e-05	0.000193	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	3.21e-05	0.000191	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CRP—periodontitis	3.21e-05	0.000191	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—ACP5—periodontitis	3.19e-05	0.00019	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—TGFB1—periodontitis	3.19e-05	0.00019	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—TLR4—periodontitis	3.08e-05	0.000183	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—SLC52A3—periodontitis	3.06e-05	0.000183	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ACP5—periodontitis	3e-05	0.000179	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	3e-05	0.000179	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ACP5—periodontitis	3e-05	0.000179	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—TNF—periodontitis	2.98e-05	0.000177	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—NTRK1—periodontitis	2.97e-05	0.000177	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—MMP9—periodontitis	2.95e-05	0.000176	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—periodontitis	2.89e-05	0.000173	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	2.85e-05	0.00017	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ACP5—periodontitis	2.83e-05	0.000169	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—NTRK1—periodontitis	2.82e-05	0.000168	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—MMP3—periodontitis	2.77e-05	0.000165	CbGpPWpGaD
Thalidomide—FGFR2—Disease—NOS2—periodontitis	2.7e-05	0.000161	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—periodontitis	2.64e-05	0.000157	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—MMP3—periodontitis	2.62e-05	0.000156	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	2.53e-05	0.000151	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—FGF2—periodontitis	2.51e-05	0.00015	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—TGFB1—periodontitis	2.43e-05	0.000145	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—IL6—periodontitis	2.4e-05	0.000143	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—FGF2—periodontitis	2.39e-05	0.000142	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IFNG—periodontitis	2.36e-05	0.000141	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	2.34e-05	0.000139	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ACP5—periodontitis	2.32e-05	0.000138	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	2.26e-05	0.000134	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IFNG—periodontitis	2.24e-05	0.000134	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—GGT1—periodontitis	2.24e-05	0.000133	CbGpPWpGaD
Thalidomide—FGFR2—Disease—FGF2—periodontitis	2.2e-05	0.000131	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—IL6—periodontitis	2.12e-05	0.000126	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ACP5—periodontitis	2.11e-05	0.000126	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL1B—periodontitis	2.11e-05	0.000126	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—periodontitis	2.07e-05	0.000123	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—IL6—periodontitis	2.01e-05	0.00012	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL1B—periodontitis	2e-05	0.000119	CbGpPWpGaD
Thalidomide—FGFR2—Disease—PTGS2—periodontitis	1.99e-05	0.000118	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—periodontitis	1.89e-05	0.000113	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—IL6—periodontitis	1.83e-05	0.000109	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ACP5—periodontitis	1.81e-05	0.000108	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CCL2—periodontitis	1.8e-05	0.000107	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—GGT1—periodontitis	1.78e-05	0.000106	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CCL2—periodontitis	1.71e-05	0.000102	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—GGT1—periodontitis	1.67e-05	9.96e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—GGT1—periodontitis	1.67e-05	9.94e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	1.65e-05	9.81e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—FGF2—periodontitis	1.63e-05	9.68e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	1.61e-05	9.62e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PPARA—periodontitis	1.6e-05	9.54e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—GGT1—periodontitis	1.58e-05	9.39e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—FGF2—periodontitis	1.54e-05	9.19e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—TGFB1—periodontitis	1.44e-05	8.56e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCL8—periodontitis	1.42e-05	8.47e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CXCL8—periodontitis	1.35e-05	8.04e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	1.35e-05	8.03e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—NOS2—periodontitis	1.34e-05	7.99e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—GGT1—periodontitis	1.29e-05	7.68e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—MMP9—periodontitis	1.29e-05	7.66e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PPARA—periodontitis	1.27e-05	7.57e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL6—periodontitis	1.24e-05	7.36e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	1.23e-05	7.32e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—MMP9—periodontitis	1.22e-05	7.27e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PPARA—periodontitis	1.2e-05	7.13e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PPARA—periodontitis	1.19e-05	7.11e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—GGT1—periodontitis	1.18e-05	7e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL6—periodontitis	1.17e-05	6.98e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PPARA—periodontitis	1.13e-05	6.72e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—FGF2—periodontitis	1.09e-05	6.52e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—IL6—periodontitis	1.08e-05	6.45e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TGFB1—periodontitis	1.06e-05	6.32e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	1.05e-05	6.25e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PTGS2—periodontitis	1.04e-05	6.2e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TGFB1—periodontitis	1.01e-05	5.99e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—GGT1—periodontitis	1e-05	5.99e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PPARA—periodontitis	9.23e-06	5.5e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PPARA—periodontitis	8.41e-06	5.01e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL6—periodontitis	7.99e-06	4.76e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PTGS2—periodontitis	7.78e-06	4.63e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PTGS2—periodontitis	7.76e-06	4.62e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL6—periodontitis	7.58e-06	4.52e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PTGS2—periodontitis	7.33e-06	4.37e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PPARA—periodontitis	7.19e-06	4.28e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—TGFB1—periodontitis	7.13e-06	4.25e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PTGS2—periodontitis	6e-06	3.58e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PTGS2—periodontitis	5.47e-06	3.26e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—IL6—periodontitis	5.37e-06	3.2e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PTGS2—periodontitis	4.67e-06	2.79e-05	CbGpPWpGaD
